An update on the post-NICU discharge management of bronchopulmonary dysplasia

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Chronic Lung Disease

Background:

• Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infancy, frequently linked to prematurity.
• Rising BPD incidence correlates with increased survival rates of extremely premature infants.
• Despite advances in neonatal care, data on established BPD outpatient management is limited.

Purpose of the Study:

• To highlight the paucity of data on long-term outpatient management for established bronchopulmonary dysplasia.
• To identify the need for high-quality research on commonly used therapies for BPD post-neonatal intensive care unit discharge.

Main Methods:

• Review of existing literature on bronchopulmonary dysplasia management.
• Analysis of the current evidence base for therapies including oxygen, bronchodilators, steroids, and diuretics.
• Identification of research gaps in long-term outcome studies.

Main Results:

• Limited high-quality studies and randomized controlled trials exist for outpatient BPD management.
• Current research often focuses on short-term effects of therapies, not long-term outcomes.
• Evidence is insufficient to guide optimal long-term treatment strategies for established BPD.

Conclusions:

• Further research is crucial to understand the long-term impact of current treatments on patients with established BPD.
• Improved understanding is needed for effective post-discharge care and management of BPD.
• High-quality trials are necessary to inform evidence-based outpatient management of BPD.